Theragen Etex Co.,Ltd. (KOSDAQ: 066700)

Theragen Etex Co.,Ltd. Statistics

Total Valuation

Theragen Etex Co.,Ltd. has a market cap or net worth of KRW 101.78 billion. The enterprise value is 137.53 billion.

Market Cap	101.78B
Enterprise Value	137.53B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Theragen Etex Co.,Ltd. has 32.01 million shares outstanding. The number of shares has increased by 1.23% in one year.

Current Share Class	n/a
Shares Outstanding	32.01M
Shares Change (YoY)	+1.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.25%
Owned by Institutions (%)	1.03%
Float	26.54M

Valuation Ratios

The trailing PE ratio is 3.74.

PE Ratio	3.74
Forward PE	n/a
PS Ratio	0.42
PB Ratio	0.63
P/TBV Ratio	n/a
P/FCF Ratio	74.48
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.24, with an EV/FCF ratio of 100.64.

EV / Earnings	5.17
EV / Sales	0.57
EV / EBITDA	7.24
EV / EBIT	10.65
EV / FCF	100.64

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.23.

Current Ratio	1.31
Quick Ratio	0.94
Debt / Equity	0.23
Debt / EBITDA	2.11
Debt / FCF	30.69
Interest Coverage	5.42

Financial Efficiency

Return on equity (ROE) is 17.79% and return on invested capital (ROIC) is 4.19%.

Return on Equity (ROE)	17.79%
Return on Assets (ROA)	3.20%
Return on Capital (ROIC)	4.19%
Revenue Per Employee	1.20B
Profits Per Employee	131.63M
Employee Count	202
Asset Turnover	0.90
Inventory Turnover	4.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.47%
50-Day Moving Average	3,457.30
200-Day Moving Average	3,854.10
Relative Strength Index (RSI)	33.09
Average Volume (20 Days)	129,185

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Theragen Etex Co.,Ltd. had revenue of KRW 241.95 billion and earned 26.59 billion in profits. Earnings per share was 825.72.

Revenue	241.95B
Gross Profit	118.17B
Operating Income	13.81B
Pretax Income	32.38B
Net Income	26.59B
EBITDA	19.89B
EBIT	13.81B
Earnings Per Share (EPS)	825.72

Balance Sheet

The company has 25.53 billion in cash and 41.94 billion in debt, giving a net cash position of -16.41 billion or -512.78 per share.

Cash & Cash Equivalents	25.53B
Total Debt	41.94B
Net Cash	-16.41B
Net Cash Per Share	-512.78
Equity (Book Value)	181.43B
Book Value Per Share	5,064.45
Working Capital	29.93B

Cash Flow

In the last 12 months, operating cash flow was 8.04 billion and capital expenditures -6.67 billion, giving a free cash flow of 1.37 billion.

Operating Cash Flow	8.04B
Capital Expenditures	-6.67B
Free Cash Flow	1.37B
FCF Per Share	42.70

Margins

Gross margin is 48.84%, with operating and profit margins of 5.71% and 10.99%.

Gross Margin	48.84%
Operating Margin	5.71%
Pretax Margin	13.38%
Profit Margin	10.99%
EBITDA Margin	8.22%
EBIT Margin	5.71%
FCF Margin	0.56%

Dividends & Yields

Theragen Etex Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	0.37%
Buyback Yield	-1.23%
Shareholder Yield	-1.23%
Earnings Yield	25.97%
FCF Yield	1.34%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Theragen Etex Co.,Ltd. has an Altman Z-Score of 2.02. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.02
Piotroski F-Score	n/a